- Home
- GRCE vs RDI Comparison
GRCE vs RDI Comparison
Compare GRCE & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- RDI
- Stock Information
- Founded
- GRCE 2002
- RDI 1937
- Country
- GRCE United States
- RDI United States
- Employees
- GRCE N/A
- RDI N/A
- Industry
- GRCE
- RDI Movies/Entertainment
- Sector
- GRCE
- RDI Consumer Discretionary
- Exchange
- GRCE NYSE
- RDI Nasdaq
- Market Cap
- GRCE 32.1M
- RDI 30.1M
- IPO Year
- GRCE N/A
- RDI N/A
- Fundamental
- Price
- GRCE $2.31
- RDI $1.31
- Analyst Decision
- GRCE Strong Buy
- RDI Hold
- Analyst Count
- GRCE 1
- RDI 1
- Target Price
- GRCE $12.00
- RDI $2.40
- AVG Volume (30 Days)
- GRCE 27.2K
- RDI 46.2K
- Earning Date
- GRCE 05-15-2025
- RDI 03-31-2025
- Dividend Yield
- GRCE N/A
- RDI N/A
- EPS Growth
- GRCE N/A
- RDI N/A
- EPS
- GRCE N/A
- RDI N/A
- Revenue
- GRCE N/A
- RDI $210,527,000.00
- Revenue This Year
- GRCE N/A
- RDI $16.31
- Revenue Next Year
- GRCE N/A
- RDI $6.78
- P/E Ratio
- GRCE N/A
- RDI N/A
- Revenue Growth
- GRCE N/A
- RDI N/A
- 52 Week Low
- GRCE $2.07
- RDI $1.22
- 52 Week High
- GRCE $4.97
- RDI $1.90
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- RDI 43.93
- Support Level
- GRCE N/A
- RDI $1.23
- Resistance Level
- GRCE N/A
- RDI $1.49
- Average True Range (ATR)
- GRCE 0.00
- RDI 0.11
- MACD
- GRCE 0.00
- RDI 0.00
- Stochastic Oscillator
- GRCE 0.00
- RDI 22.86
Stock Price Comparison Chart: GRCE vs RDI
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.